BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2014

Jul 28, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2014-07-25

Reporting Person: STAAB THOMAS R II (Senior Vice President and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-25	Common Stock	M	26455	$3.78	Acquired	170756	Direct
2014-07-25	Common Stock	F	8504	$11.76	Disposed	162252	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-25	Stock Option (Right to Buy)	$3.78	M	26455	Disposed	2021-07-01	Common Stock (26455)	Direct

Footnotes

F1: Shares of Common Stock withheld to satisfy payment of exercise price for stock option exercise.